Top companies blasted for secrecy

Researchers are calling on the pharma industry to make clinical trial data underpinning cancer drug approvals available as soon as they are registered, after finding more than half of the data remains hidden.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here